Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Potential Association between Sickle Trait and MRI-Defined Cerebrovascular Outcomes in Two Multi-Ethnic Elderly Populations
source: American Society of Hematology
year: 2017
authors: Nancy S. Green, Rashid Halloway, Adam M. Brickman, Giuseppe Tosto, Clinton B. Wright, Chuanhui Dong, Liyong Wang, Ralph L. Sacco, Mitchell S.V. Elkind, Jose Gutierrez, Sandra Barral
summary/abstract:Sickle cell disease is a risk factor for stroke. Findings from previous studies examining an association between sickle trait and stroke have been conflicting (Roach ES, 2005; Caughey MC, et al, 2014).An estimated two million people in the United States (U.S.) carry sickle trait (Key NS, et al, 2015). Carrier prevalence among African American newborns is 7-8% and up to 4% among Caribbean Hispanics, especially among people from the Dominican Republic and certain other nationalities (Lorey FW, et al, 1996; Siddiqui S, et al, 2012). Trait carriers are at increased risk of renal papillary necrosis, chronic kidney disease and thrombosis (Naik RP, et al, Bucknor MD, et al, 2014; Porter B, et, 2014). We hypothesized that cohorts of high-risk elderly populations who carry sickle trait may provide an opportunity to examine the question of cerebrovascular risk within the context of other associated risk factors.
Methods: We examined cross-sectional associations between sickle trait and MRI-defined cerebral infarct and small vessel abnormalities, defined by a quantitative trait of white matter hyperintensities (WMHs), in 1476 participants from two well-phenotyped, high-risk elderly population-based cohorts, the Washington Heights-Inwood Columbia Aging Project (WHICAP) (Brickman AM, et, 2008 and 2010) and the Northern Manhattan Study (NOMAS) (Monteith T, et al, 2014). Participants shared by the cohorts were eliminated from WHICAP data. All 536 African American and 940 Caribbean Hispanic participants in the combined cohorts were genotyped for sickle trait. MRI protocols and WMH phenotyping used in both cohorts were performed as previously described using a 1.5T scanner and common pathologically-informed algorithms with good intra-reader reliability (Brickman AM, 2008; Verhaaren BF, 2015; Gutierrez J, et al, 2015). Univariate and multivariable-adjusted analyses were performed with statistical software packages SAS, SPSS and R. Beta coefficients from the linear regression models (WMH as the outcome variable) were exponentiated for interpretation as odds ratios.
organization: Columbia U. Medical Center Div. of Pediatric Hematology/Oncology/Stem Cell Trans, New York, NY; Columbia University, New York; The National Institute of Neurological Disorders and Stroke (NINDS), Bethesda; University of Miami, Miami; Columbia University Medical Center, New York, NYread more
+myBinderRelated Content
-
Researchers Identify Genetic Predictors of Sickle Cell Anemia-Related ComplicationsPatients with sickle cell anemia who do ...
-
Cardiovascular Complications and Risk of Death in Sickle-cell DiseaseIn sickle-cell disease, a point mutation...
-
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH ...Background: Sickle cell anemia (SCA) i...
-
Fighting Through Our Pain TV With Thomas J. Harrington MDhttps://www.youtube.com/watch?time_conti...
-
How This Disease Changes the Shape of Your Cells – Amber M. Yateshttps://www.youtube.com/watch?v=hRnrIpUM...
-
Sickle cell + History: An episode of the sickle cell podcastThe Sickle Cell Podcast is an effort by ...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.